FDA Approves Samsca to treat Hyponatremia The U.S. Food and
FDA Approves Samsca to treat Hyponatremia
The U.S. Food and Drug Administration has approved Samsca tablets (tolvaptan) to treat hyponatremia, an abnormally low concentration of sodium in the blood.